An observational study to characterize severe eosinophilic asthma in New Zealand

被引：2
|
作者：
Shantakumar, Sumitra [1 ]
Ho, Yu-Fan [1 ]
Beale, Janine [2 ]
Gribben, Barry [3 ]
机构：
[1] GlaxoSmithKline, Singapore, Singapore
[2] GlaxoSmithKline, Auckland, New Zealand
[3] CBG Hlth Res, Auckland, New Zealand
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA1155
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1155
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mepolizumab (Nucala) for Severe Eosinophilic Asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1486): : 11 - 12
  • [32] Clusters of Severe Eosinophilic Asthma in a Korean Asthma Cohort
    Lee, Ji-Hyang
    An, Jin
    Won, Ha-Kyeong
    Seo, Bomi
    Kim, Jung-Hyun
    Park, So-Young
    Kim, Min-Hye
    Shin, Yoo Seob
    Jung, Jae-Woo
    Song, Woo-Jung
    Lee, Taehoon
    Kwon, Hyouk-Soo
    Lee, Jae Hyun
    Kim, Joo-Hee
    Kim, Sae-Hoon
    Chang, Yoon-Seok
    Cho, You Sook
    Nahm, Dong-Ho
    Jang, An-Soo
    Park, Jung-Won
    Yoon, Ho-Joo
    Cho, Sang-Heon
    Cho, Young-Joo
    Choi, Byoung Whui
    Moon, Hee-Bom
    Kim, Tae-Bum
    RESPIRATION, 2022, 101 (05) : 465 - 475
  • [33] Mepolizumab for the treatment of severe eosinophilic asthma
    Poulakos, Mara N.
    Cargill, Shawna M.
    Waineo, Melissa F.
    Wolford, Allen L., Jr.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (13) : 963 - 969
  • [34] Prognostic factors in severe eosinophilic asthma
    Padro Casas, C.
    Basagana Torrento, M.
    Martinez Colls, M. D. M.
    Rivera Ortun, M.
    Pollan Guisasola, C.
    Navarro Ferrando, J. T.
    Martinez Caceres, E.
    Teniente Serra, A.
    Francoso Vicente, A.
    Ruiz Manzano, J.
    Roger Reig, A.
    Martinez Rivera, C.
    ALLERGY, 2018, 73 : 668 - 668
  • [35] Prognostic factors in severe eosinophilic asthma
    Dos Santos Carvalho, Filipe Goncalves
    Padro Casas, Clara
    Basagana Torrento, Maria
    Rivera Ortun, Marisa
    Martinez Colls, Maria Del Mar
    Pollan Guisasola, Carlos
    Francoso Vicente, Alicia
    Martinez Caceres, Eva
    Teniente, Aina
    Roger, Albert
    Ruiz Manzano, Juan
    Martinez Rivera, Carlos
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [36] BIOLOGICS SWITCH IN SEVERE EOSINOPHILIC ASTHMA
    Caminati, Marco
    Guarnieri, Gabriella
    Bagnasco, Diego
    Bianchi, Fulvia Chieco
    Carpagnano, Elisiana
    Maule, Matteo
    Molena, Beatrice
    Pelaia, Girolamo
    Pini, Laura
    Senna, Gianenrico
    Vianello, Andrea
    Crisafulli, Ernesto
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [37] Severe eosinophilic asthma: a roadmap to consensus
    Buhl, Roland
    Humbert, Marc
    Bjermer, Leif
    Chanez, Pascal
    Heaney, Liam G.
    Pavord, Ian
    Quirce, Santiago
    Virchow, Johann C.
    Holgate, Stephen
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [38] Features of severe asthma in primary care - an observational study
    Telg, Gunilla
    Larsson, Kjell
    Stallberg, Bjorn
    Lisspers, Karin
    Johansson, Gunnar
    Janson, Christer
    Thuresson, Marcus
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [39] Reslizumab (Cinqair) for Severe Eosinophilic Asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1497): : 81 - 82
  • [40] Mepolizumab in the treatment of severe eosinophilic asthma
    Fainardi, Valentina
    Pisi, Giovanna
    Chetta, Alfredo
    IMMUNOTHERAPY, 2016, 8 (01) : 27 - 34
12345